Anika Therapeutics (ANIK) Other Non-Current Assets (2010 - 2026)

Anika Therapeutics (ANIK) has 17 years of Other Non-Current Assets data on file, last reported at $4.3 million in Q1 2026.

• Other Non-Current Assets for Q1 2026 came in at $4.3 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $4.3 million (changed N/A YoY), and the FY2025 annual result was $4.0 million, down 28.68% from the prior year.
• Other Non-Current Assets rose to $4.3 million in Q1 2026 per ANIK's latest filing, from $4.0 million in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $36.3 million in Q4 2023 and troughed at $4.0 million in Q4 2025.
• A 5-year average of $15.8 million and a median of $18.1 million in 2023 frame the typical range for Other Non-Current Assets.
• The sharpest annual moves came in 2023 and 2024: Other Non-Current Assets surged 110.84% in 2023, then slumped 84.42% in 2024.
• A 5-year view of Other Non-Current Assets shows it stood at $17.2 million in 2022, then jumped by 110.84% to $36.3 million in 2023, then tumbled by 84.42% to $5.7 million in 2024, then retreated by 28.68% to $4.0 million in 2025, then increased by 6.67% to $4.3 million in 2026.
• Business Quant data shows ANIK's Other Non-Current Assets at $4.3 million in Q1 2026, $4.0 million in Q4 2025, and $5.5 million in Q3 2025.